Huntington SF, von Keudell G, Davidoff AJ, Gross CP, et al. Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma. J Clin Oncol 2018 Oct 4:JCO1800122. doi: 10.1200/JCO.18.00122.
PMID: 30285558